ID: ALA3827530

Max Phase: Preclinical

Molecular Formula: C9H6N6

Molecular Weight: 198.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(-c2ccnc3nnnn23)nc1

Standard InChI:  InChI=1S/C9H6N6/c1-2-5-10-7(3-1)8-4-6-11-9-12-13-14-15(8)9/h1-6H

Standard InChI Key:  FHQOPFZJUZOMNM-UHFFFAOYSA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase MAL12 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 198.19Molecular Weight (Monoisotopic): 198.0654AlogP: 0.58#Rotatable Bonds: 1
Polar Surface Area: 68.86Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.14CX LogP: 0.59CX LogD: 0.59
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.57Np Likeness Score: -2.32

References

1. Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV..  (2016)  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.,  26  (16): [PMID:27406797] [10.1016/j.bmcl.2016.06.086]

Source